{"transactions":[{"id":310946,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:07:24.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":76,"price":102.67,"value":7802.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10544,"derivative":{"underlying":"Common Shares","underlying_shares":76},"source":{"system":"sec-edgar","filing":"0001448074-26-000008","document":"form4-04022026_090418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000144807426000008/form4-04022026_090418.xml","form_type":"4"}},{"id":10999,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:00:11.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":35,"price":217.49,"value":7612.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10369,"derivative":{"exercise_price":217.49,"underlying":"Common Stock","underlying_shares":35},"source":{"system":"sec-edgar","filing":"0001448074-26-000007","document":"form4-04022026_050406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000144807426000007/form4-04022026_050406.xml","form_type":"4"}},{"id":315559,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T23:00:56.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":62,"price":125.29,"value":7767.98,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10409,"derivative":{"underlying":"Common Shares","underlying_shares":62},"source":{"system":"sec-edgar","filing":"0001448074-26-000004","document":"form4-01052026_110149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000144807426000004/form4-01052026_110149.xml","form_type":"4"}},{"id":15629,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T22:00:18.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":34,"price":228.49,"value":7768.66,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10257,"derivative":{"exercise_price":228.49,"underlying":"Common Stock","underlying_shares":34},"source":{"system":"sec-edgar","filing":"0001448074-26-000003","document":"form4-01052026_050110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000144807426000003/form4-01052026_050110.xml","form_type":"4"}},{"id":18854,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T21:00:17.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":33,"price":231.54,"value":7640.82,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10151,"derivative":{"exercise_price":231.54,"underlying":"Common Stock","underlying_shares":33},"source":{"system":"sec-edgar","filing":"0001448074-25-000012","document":"form4-10022025_051004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000144807425000012/form4-10022025_051004.xml","form_type":"4"}},{"id":318351,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T20:34:54.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":58,"price":133.94,"value":7768.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10300,"derivative":{"underlying":"Common Shares","underlying_shares":58},"source":{"system":"sec-edgar","filing":"0001448074-25-000011","document":"form4-10022025_081051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000144807425000011/form4-10022025_081051.xml","form_type":"4"}},{"id":22043,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-07-02T21:00:13.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":40,"price":185.62,"value":7424.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10038,"derivative":{"exercise_price":185.62,"underlying":"Common Stock","underlying_shares":40},"source":{"system":"sec-edgar","filing":"0001415889-25-019106","document":"form4-07022025_050704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588925019106/form4-07022025_050704.xml","form_type":"4"}},{"id":321066,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-07-01T21:05:40.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":57,"price":136.01,"value":7752.57,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10195,"derivative":{"underlying":"Common Shares","underlying_shares":57},"source":{"system":"sec-edgar","filing":"0001415889-25-018729","document":"form4-07012025_090737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925018729/form4-07012025_090737.xml","form_type":"4"}},{"id":24077,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2025-05-13T21:05:08.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":1203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from\nservice, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":35646,"source":{"system":"sec-edgar","filing":"0001415889-25-012793","document":"form4-05132025_050503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588925012793/form4-05132025_050503.xml","form_type":"4"}},{"id":322695,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2025-04-29T21:03:46.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":40798,"source":{"system":"sec-edgar","filing":"0001415889-25-011510","document":"form4-04292025_090442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925011510/form4-04292025_090442.xml","form_type":"4"}},{"id":323431,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-04-02T21:05:44.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":59,"price":132.65,"value":7826.35,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10093,"derivative":{"underlying":"Common Shares","underlying_shares":59},"source":{"system":"sec-edgar","filing":"0001415889-25-009706","document":"form4-04022025_090440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925009706/form4-04022025_090440.xml","form_type":"4"}},{"id":25226,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-04-02T21:00:16.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":35,"price":209.52,"value":7333.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9907,"derivative":{"exercise_price":209.52,"underlying":"Common Stock","underlying_shares":35},"source":{"system":"sec-edgar","filing":"0001415889-25-009691","document":"form4-04022025_050412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588925009691/form4-04022025_050412.xml","form_type":"4"}},{"id":327591,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-01-03T22:02:12.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":69,"price":113.11,"value":7804.59,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9988,"derivative":{"underlying":"Common Shares","underlying_shares":69},"source":{"system":"sec-edgar","filing":"0001415889-25-000528","document":"form4-01032025_100102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925000528/form4-01032025_100102.xml","form_type":"4"}},{"id":30892,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-01-03T22:00:12.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":42,"price":177.7,"value":7463.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9788,"derivative":{"exercise_price":177.7,"underlying":"Common Stock","underlying_shares":42},"source":{"system":"sec-edgar","filing":"0001415889-25-000521","document":"form4-01032025_050107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588925000521/form4-01032025_050107.xml","form_type":"4"}},{"id":35040,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-10-02T21:00:12.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":37,"price":197.48,"value":7306.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9655,"derivative":{"exercise_price":197.48,"underlying":"Common Stock","underlying_shares":37},"source":{"system":"sec-edgar","filing":"0001415889-24-024452","document":"form4-10022024_051007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588924024452/form4-10022024_051007.xml","form_type":"4"}},{"id":330412,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-10-01T21:27:14.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":69,"price":114.01,"value":7866.69,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9872,"derivative":{"underlying":"Common Shares","underlying_shares":69},"source":{"system":"sec-edgar","filing":"0001415889-24-024236","document":"form4-10012024_091011.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924024236/form4-10012024_091011.xml","form_type":"4"}},{"id":332344,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-07-02T20:22:29.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":75,"price":103.91,"value":7793.25,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9754,"derivative":{"underlying":"Common Shares","underlying_shares":75},"source":{"system":"sec-edgar","filing":"0001415889-24-018885","document":"form4-07022024_080725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924018885/form4-07022024_080725.xml","form_type":"4"}},{"id":38651,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true}}],"security":"Stock Equivalent Units","published_at":"2024-07-02T20:18:45.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":43,"price":171.52,"value":7375.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9541,"derivative":{"exercise_price":171.52,"underlying":"Common Stock","underlying_shares":43},"source":{"system":"sec-edgar","filing":"0000897069-24-001471","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000089706924001471/form4.xml","form_type":"4"}},{"id":41199,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2024-05-07T22:30:44.000Z","date":"2024-05-03","kind":"grant","planned":false,"acquired":true,"shares":1322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":34443,"source":{"system":"sec-edgar","filing":"0001415889-24-012527","document":"form4-05072024_060528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588924012527/form4-05072024_060528.xml","form_type":"4"}},{"id":334329,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2024-04-30T21:33:15.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":1866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":39163,"source":{"system":"sec-edgar","filing":"0001415889-24-011784","document":"form4-04302024_090408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924011784/form4-04302024_090408.xml","form_type":"4"}},{"id":335914,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-04-02T22:32:25.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":69,"price":113.66,"value":7842.54,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9628,"derivative":{"underlying":"Common Shares","underlying_shares":69},"source":{"system":"sec-edgar","filing":"0001415889-24-009860","document":"form4-04022024_100416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924009860/form4-04022024_100416.xml","form_type":"4"}},{"id":42129,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-04-02T21:00:33.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":41,"price":182.1,"value":7466.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9408,"derivative":{"exercise_price":182.1,"underlying":"Common Stock","underlying_shares":41},"source":{"system":"sec-edgar","filing":"0001415889-24-009802","document":"form4-04022024_050408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588924009802/form4-04022024_050408.xml","form_type":"4"}},{"id":342872,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-01-03T22:28:37.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":71,"price":110.07,"value":7814.97,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9512,"derivative":{"underlying":"Common Shares","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001415889-24-000359","document":"form4-01032024_100123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588924000359/form4-01032024_100123.xml","form_type":"4"}},{"id":48931,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2024-01-03T22:08:30.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":48,"price":154.97,"value":7438.56,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9285,"derivative":{"exercise_price":154.97,"underlying":"Common Stock","underlying_shares":48},"source":{"system":"sec-edgar","filing":"0001415889-24-000335","document":"form4-01032024_100107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588924000335/form4-01032024_100107.xml","form_type":"4"}},{"id":345385,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-10-03T22:45:01.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":81,"price":96.85,"value":7844.85,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9392,"derivative":{"underlying":"Common Shares","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0001415889-23-013947","document":"form4-10032023_101054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923013947/form4-10032023_101054.xml","form_type":"4"}},{"id":52236,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-10-03T21:00:37.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":50,"price":149.06,"value":7453.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9139,"derivative":{"exercise_price":149.06,"underlying":"Common Stock","underlying_shares":50},"source":{"system":"sec-edgar","filing":"0001415889-23-013895","document":"form4-10032023_051001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588923013895/form4-10032023_051001.xml","form_type":"4"}},{"id":52778,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2023-09-11T21:00:10.000Z","date":"2023-09-07","kind":"other","planned":false,"acquired":true,"shares":129,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33121,"source":{"system":"sec-edgar","filing":"0001415889-23-013148","document":"form4-09112023_050901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588923013148/form4-09112023_050901.xml","form_type":"4"}},{"id":54530,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-07-05T21:00:09.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":55,"price":134.73,"value":7410.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9001,"derivative":{"exercise_price":134.73,"underlying":"Common Stock","underlying_shares":55},"source":{"system":"sec-edgar","filing":"0001415889-23-010773","document":"form4-07052023_050701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588923010773/form4-07052023_050701.xml","form_type":"4"}},{"id":347854,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-07-05T15:54:21.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":72,"price":109.02,"value":7849.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9266,"derivative":{"underlying":"Common Shares","underlying_shares":72},"source":{"system":"sec-edgar","filing":"0001104659-23-077918","document":"tm2320556-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465923077918/tm2320556-1_4seq1.xml","form_type":"4"}},{"id":56072,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2023-05-09T21:00:14.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":1450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":32992,"source":{"system":"sec-edgar","filing":"0001415889-23-007664","document":"form4-05092023_050502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588923007664/form4-05092023_050502.xml","form_type":"4"}},{"id":349552,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2023-05-02T23:37:08.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":1816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":37297,"source":{"system":"sec-edgar","filing":"0001415889-23-007126","document":"form4-05022023_110558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923007126/form4-05022023_110558.xml","form_type":"4"}},{"id":350431,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-04-04T23:25:10.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":77,"price":101.26,"value":7797.02,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9151,"derivative":{"underlying":"Common Shares","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001415889-23-006148","document":"form4-04042023_110402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923006148/form4-04042023_110402.xml","form_type":"4"}},{"id":56813,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-04-04T21:00:43.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":47,"price":159.37,"value":7490.39,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8856,"derivative":{"exercise_price":159.37,"underlying":"Common Stock","underlying_shares":47},"source":{"system":"sec-edgar","filing":"0001415889-23-006074","document":"form4-04042023_050406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588923006074/form4-04042023_050406.xml","form_type":"4"}},{"id":355276,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-01-04T23:09:51.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":71,"price":109.79,"value":7795.09,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":9030,"derivative":{"underlying":"Common Shares","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001415889-23-000426","document":"form4-01042023_110134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923000426/form4-01042023_110134.xml","form_type":"4"}},{"id":60392,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2023-01-03T22:06:24.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":46,"price":161.61,"value":7434.06,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8723,"derivative":{"exercise_price":161.61,"underlying":"Common Stock","underlying_shares":46},"source":{"system":"sec-edgar","filing":"0001415889-23-000087","document":"form4-01032023_100102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588923000087/form4-01032023_100102.xml","form_type":"4"}},{"id":2104179,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-25T21:13:54.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":131879,"price":0.21,"value":27694.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.21 to $0.22, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001595585-22-000093","document":"wf-form4_166941082049026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558522000093/wf-form4_166941082049026.xml","form_type":"4"}},{"id":2106819,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T01:33:01.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":27584,"price":0.23,"value":6344.32,"ownership":{"direct":true},"balance_after":131879,"source":{"system":"sec-edgar","filing":"0001595585-22-000091","document":"wf-form4_166916716773671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558522000091/wf-form4_166916716773671.xml","form_type":"4"}},{"id":357708,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-10-04T21:21:52.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":81,"price":96.76,"value":7837.56,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8918,"derivative":{"underlying":"Common Shares","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0001415889-22-010261","document":"form4-10042022_021033.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922010261/form4-10042022_021033.xml","form_type":"4"}},{"id":62893,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-10-04T21:02:53.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":55,"price":134.21,"value":7381.55,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8598,"derivative":{"exercise_price":134.21,"underlying":"Common Stock","underlying_shares":55},"source":{"system":"sec-edgar","filing":"0001415889-22-010242","document":"form4-10042022_021018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588922010242/form4-10042022_021018.xml","form_type":"4"}},{"id":64974,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-07-05T21:25:55.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":47,"price":153.16,"value":7198.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8458,"derivative":{"exercise_price":153.16,"underlying":"Common Stock","underlying_shares":47},"source":{"system":"sec-edgar","filing":"0001415889-22-007380","document":"form4-07052022_020740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000141588922007380/form4-07052022_020740.xml","form_type":"4"}},{"id":359988,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-07-01T20:24:25.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":72,"price":108.65,"value":7822.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8800,"derivative":{"underlying":"Common Shares","underlying_shares":72},"source":{"system":"sec-edgar","filing":"0001415889-22-007169","document":"form4-07012022_010708.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922007169/form4-07012022_010708.xml","form_type":"4"}},{"id":2229876,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:34:33.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":27207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of June 15, 2022 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Option Date (the \"Next Annual Meeting\") occurs prior to the Vesting Date, then the option shall vest in full one day prior to the Next Annual Meeting."}],"balance_after":27207,"derivative":{"exercise_price":9.87,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":27207},"source":{"system":"sec-edgar","filing":"0001595585-22-000057","document":"wf-form4_165541165921267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558522000057/wf-form4_165541165921267.xml","form_type":"4"}},{"id":66490,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-09T21:09:49.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":1421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":31542,"source":{"system":"sec-edgar","filing":"0001179110-22-002924","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911022002924/edgar.xml","form_type":"4"}},{"id":361936,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2022-05-03T21:49:27.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":1602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":35481,"source":{"system":"sec-edgar","filing":"0001415889-22-004546","document":"form4-05032022_020514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922004546/form4-05032022_020514.xml","form_type":"4"}},{"id":67980,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-04-04T21:14:22.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":44,"price":162.11,"value":7132.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8335,"derivative":{"exercise_price":162.11,"underlying":"Common Stock","underlying_shares":44},"source":{"system":"sec-edgar","filing":"0001179110-22-002544","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911022002544/edgar.xml","form_type":"4"}},{"id":363232,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-04-01T21:21:05.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":66,"price":118.36,"value":7811.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8690,"derivative":{"underlying":"Common Shares","underlying_shares":66},"source":{"system":"sec-edgar","filing":"0001415889-22-003587","document":"form4-04012022_020455.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922003587/form4-04012022_020455.xml","form_type":"4"}},{"id":367816,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-01-04T22:17:16.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":55,"price":140.74,"value":7740.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8591,"derivative":{"underlying":"Common Shares","underlying_shares":55},"source":{"system":"sec-edgar","filing":"0001415889-22-000228","document":"form4-01042022_020147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922000228/form4-01042022_020147.xml","form_type":"4"}},{"id":73622,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2022-01-04T22:02:08.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":53,"price":135.4,"value":7176.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8210,"derivative":{"exercise_price":135.4,"underlying":"Common Stock","underlying_shares":53},"source":{"system":"sec-edgar","filing":"0001179110-22-000118","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911022000118/edgar.xml","form_type":"4"}},{"id":370958,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-10-04T21:27:17.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":66,"price":118.13,"value":7796.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8505,"derivative":{"underlying":"Common Shares","underlying_shares":66},"source":{"system":"sec-edgar","filing":"0001415889-21-004707","document":"form4-10042021_021007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921004707/form4-10042021_021007.xml","form_type":"4"}},{"id":79733,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-10-04T21:04:14.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":66,"price":107.87,"value":7119.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8068,"derivative":{"exercise_price":107.87,"underlying":"Common Stock","underlying_shares":66},"source":{"system":"sec-edgar","filing":"0001179110-21-009160","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911021009160/edgar.xml","form_type":"4"}},{"id":373816,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-07-02T21:01:28.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":67,"price":115.93,"value":7767.31,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8408,"derivative":{"underlying":"Common Shares","underlying_shares":67},"source":{"system":"sec-edgar","filing":"0001415889-21-003418","document":"form4-07022021_020756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921003418/form4-07022021_020756.xml","form_type":"4"}},{"id":84915,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-07-02T13:08:57.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":63,"price":112.67,"value":7098.21,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7914,"derivative":{"exercise_price":112.67,"underlying":"Common Stock","underlying_shares":63},"source":{"system":"sec-edgar","filing":"0001179110-21-007282","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911021007282/edgar.xml","form_type":"4"}},{"id":2671795,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T21:07:36.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":57235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of June 10, 2021 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting."}],"balance_after":57235,"derivative":{"exercise_price":4.92,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":57235},"source":{"system":"sec-edgar","filing":"0001595585-21-000076","document":"wf-form4_162344563392461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558521000076/wf-form4_162344563392461.xml","form_type":"4"}},{"id":2671794,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T21:07:36.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":16403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of June 10, 2021 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":159463,"source":{"system":"sec-edgar","filing":"0001595585-21-000076","document":"wf-form4_162344563392461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558521000076/wf-form4_162344563392461.xml","form_type":"4"}},{"id":87971,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2021-05-11T21:05:15.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":1681,"price":115.96,"value":194928.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":30121,"source":{"system":"sec-edgar","filing":"0001179110-21-005197","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911021005197/edgar.xml","form_type":"4"}},{"id":376350,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2021-04-27T22:59:42.000Z","date":"2021-04-23","kind":"grant","acquired":true,"shares":1499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":33879,"source":{"system":"sec-edgar","filing":"0001415889-21-002154","document":"form4-04272021_030431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921002154/form4-04272021_030431.xml","form_type":"4"}},{"id":377169,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-04-02T21:30:55.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":65,"price":119.84,"value":7789.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8308,"derivative":{"underlying":"Common Shares","underlying_shares":65},"source":{"system":"sec-edgar","filing":"0001415889-21-001831","document":"form4-04022021_020445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001831/form4-04022021_020445.xml","form_type":"4"}},{"id":90175,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-04-01T20:43:59.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":66,"price":108.22,"value":7142.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7764,"derivative":{"exercise_price":108.22,"underlying":"Common stock","underlying_shares":66},"source":{"system":"sec-edgar","filing":"0001179110-21-003957","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911021003957/edgar.xml","form_type":"4"}},{"id":382038,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-01-05T23:32:23.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":71,"price":109.49,"value":7773.79,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8214,"derivative":{"underlying":"Common Shares","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001415889-21-000152","document":"form4-01052021_030112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000152/form4-01052021_030112.xml","form_type":"4"}},{"id":95956,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2021-01-05T22:01:13.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":67,"price":107.15,"value":7179.05,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7602,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":67},"source":{"system":"sec-edgar","filing":"0001179110-21-000194","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911021000194/edgar.xml","form_type":"4"}},{"id":100585,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-10-02T20:52:58.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":82,"price":87.59,"value":7182.38,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7489,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":82},"source":{"system":"sec-edgar","filing":"0001179110-20-010196","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911020010196/edgar.xml","form_type":"4"}},{"id":385295,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-10-01T21:48:14.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":72,"price":108.83,"value":7835.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8116,"derivative":{"underlying":"Common Shares","underlying_shares":72},"source":{"system":"sec-edgar","filing":"0001179110-20-010065","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020010065/edgar.xml","form_type":"4"}},{"id":103545,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-07-02T13:26:02.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":71,"price":98.18,"value":6970.78,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7353,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":71},"source":{"system":"sec-edgar","filing":"0001179110-20-007837","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911020007837/edgar.xml","form_type":"4"}},{"id":388797,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-07-01T22:17:54.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":86,"price":91.43,"value":7862.98,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":8015,"derivative":{"underlying":"Common Shares","underlying_shares":86},"source":{"system":"sec-edgar","filing":"0001104659-20-079857","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465920079857/a4.xml","form_type":"4"}},{"id":3110468,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T23:39:16.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":22967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of June 11, 2020 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting."}],"balance_after":22967,"derivative":{"exercise_price":25.4,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22967},"source":{"system":"sec-edgar","filing":"0001595585-20-000084","document":"wf-form4_159226433861659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558520000084/wf-form4_159226433861659.xml","form_type":"4"}},{"id":3110467,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T23:39:16.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of June 11, 2020 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":143060,"source":{"system":"sec-edgar","filing":"0001595585-20-000084","document":"wf-form4_159226433861659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558520000084/wf-form4_159226433861659.xml","form_type":"4"}},{"id":104914,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2020-05-12T20:57:23.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":2333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":28440,"source":{"system":"sec-edgar","filing":"0001179110-20-005775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911020005775/edgar.xml","form_type":"4"}},{"id":391449,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2020-04-28T21:20:50.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":1974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":32380,"source":{"system":"sec-edgar","filing":"0001179110-20-005178","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005178/edgar.xml","form_type":"4"}},{"id":392342,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-04-02T21:49:47.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":99,"price":78.91,"value":7812.09,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7897,"derivative":{"underlying":"Common Shares","underlying_shares":99},"source":{"system":"sec-edgar","filing":"0001179110-20-004562","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020004562/edgar.xml","form_type":"4"}},{"id":105745,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-04-02T21:01:48.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":90,"price":76.19,"value":6857.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7110,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":90},"source":{"system":"sec-edgar","filing":"0001179110-20-004513","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911020004513/edgar.xml","form_type":"4"}},{"id":397261,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2020-01-03T22:04:59.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":90,"price":86.86,"value":7817.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7766,"derivative":{"underlying":"Common shares","underlying_shares":90},"source":{"system":"sec-edgar","filing":"0001179110-20-000214","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020000214/edgar.xml","form_type":"4"}},{"id":109417,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Unites","published_at":"2020-01-03T17:41:27.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":77,"price":88.54,"value":6817.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6933,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001179110-20-000105","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911020000105/edgar.xml","form_type":"4"}},{"id":3357646,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-27T21:26:59.000Z","date":"2019-11-26","kind":"sale","acquired":false,"shares":1000,"price":39.59,"value":39590.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.20 to $39.99, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":137390,"source":{"system":"sec-edgar","filing":"0001595585-19-000267","document":"wf-form4_157489000070694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000267/wf-form4_157489000070694.xml","form_type":"4"}},{"id":3363079,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T00:09:55.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":2439,"price":40.65,"value":99145.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.21 to $40.80, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":138390,"source":{"system":"sec-edgar","filing":"0001595585-19-000263","document":"wf-form4_157438137971772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000263/wf-form4_157438137971772.xml","form_type":"4"}},{"id":3371200,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T23:54:59.000Z","date":"2019-11-12","kind":"sale","acquired":false,"shares":1159,"price":39.92,"value":46267.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.78 to $40.29, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":140829,"source":{"system":"sec-edgar","filing":"0001595585-19-000261","document":"wf-form4_157377568336808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000261/wf-form4_157377568336808.xml","form_type":"4"}},{"id":3374413,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-12T23:53:49.000Z","date":"2019-11-07","kind":"sale","acquired":false,"shares":3953,"price":39.93,"value":157843.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $40.23, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":141988,"source":{"system":"sec-edgar","filing":"0001595585-19-000252","document":"wf-form4_157360281269501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000252/wf-form4_157360281269501.xml","form_type":"4"}},{"id":3377591,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T00:24:06.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":227,"price":39.75,"value":9023.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."}],"balance_after":145941,"source":{"system":"sec-edgar","filing":"0001595585-19-000250","document":"wf-form4_157317263109524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000250/wf-form4_157317263109524.xml","form_type":"4"}},{"id":3377590,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T00:24:06.000Z","date":"2019-11-05","kind":"sale","acquired":false,"shares":1605,"price":39.89,"value":64023.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $40.27, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":146168,"source":{"system":"sec-edgar","filing":"0001595585-19-000250","document":"wf-form4_157317263109524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000250/wf-form4_157317263109524.xml","form_type":"4"}},{"id":3378685,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-07T00:27:01.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":2617,"price":39.84,"value":104261.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $40.31, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":147773,"source":{"system":"sec-edgar","filing":"0001595585-19-000247","document":"wf-form4_157308640416906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000247/wf-form4_157308640416906.xml","form_type":"4"}},{"id":3386253,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T01:16:22.000Z","date":"2019-10-25","kind":"sale","acquired":false,"shares":1000,"price":36.29,"value":36290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.92 to $36.74, inclusive."}],"balance_after":150390,"source":{"system":"sec-edgar","filing":"0001595585-19-000239","document":"wf-form4_157239815609396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000239/wf-form4_157239815609396.xml","form_type":"4"}},{"id":3386252,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T01:16:22.000Z","date":"2019-10-25","kind":"sale","acquired":false,"shares":346,"price":37.24,"value":12885.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.20 to $37.49, inclusive."}],"balance_after":151390,"source":{"system":"sec-edgar","filing":"0001595585-19-000239","document":"wf-form4_157239815609396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000239/wf-form4_157239815609396.xml","form_type":"4"}},{"id":3386251,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T01:16:22.000Z","date":"2019-10-25","kind":"sale","acquired":false,"shares":9654,"price":36.52,"value":352564.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.12 to $37.00, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3) and (4) to this Form 4."}],"balance_after":151736,"source":{"system":"sec-edgar","filing":"0001595585-19-000239","document":"wf-form4_157239815609396.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000239/wf-form4_157239815609396.xml","form_type":"4"}},{"id":399963,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-10-02T21:07:57.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":94,"price":83.67,"value":7864.98,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7647,"derivative":{"underlying":"Common shares","underlying_shares":94},"source":{"system":"sec-edgar","filing":"0001104659-19-052641","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465919052641/a4.xml","form_type":"4"}},{"id":112352,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-10-01T21:48:42.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":90,"price":75.72,"value":6814.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6773,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":90},"source":{"system":"sec-edgar","filing":"0001104659-19-052307","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000110465919052307/a4.xml","form_type":"4"}},{"id":3404391,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T00:48:18.000Z","date":"2019-09-26","kind":"sale","acquired":false,"shares":21,"price":32.63,"value":685.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.62 to $32.63, inclusive."}],"balance_after":161390,"source":{"system":"sec-edgar","filing":"0001595585-19-000215","document":"wf-form4_156989087300481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000215/wf-form4_156989087300481.xml","form_type":"4"}},{"id":3404390,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T00:48:18.000Z","date":"2019-09-26","kind":"sale","acquired":false,"shares":461,"price":32.15,"value":14821.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.47 to $32.44, inclusive."}],"balance_after":161411,"source":{"system":"sec-edgar","filing":"0001595585-19-000215","document":"wf-form4_156989087300481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000215/wf-form4_156989087300481.xml","form_type":"4"}},{"id":3404389,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T00:48:18.000Z","date":"2019-09-26","kind":"sale","acquired":false,"shares":518,"price":30.76,"value":15933.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.15, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3) and (4) to this Form 4."}],"balance_after":161872,"source":{"system":"sec-edgar","filing":"0001595585-19-000215","document":"wf-form4_156989087300481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000215/wf-form4_156989087300481.xml","form_type":"4"}},{"id":3427303,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-28T20:09:02.000Z","date":"2019-08-26","kind":"sale","acquired":false,"shares":1000,"price":33.19,"value":33190.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.89 to $33.50, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":162390,"source":{"system":"sec-edgar","filing":"0001595585-19-000186","document":"wf-form4_156702292610116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000186/wf-form4_156702292610116.xml","form_type":"4"}},{"id":3454251,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T22:56:50.000Z","date":"2019-07-25","kind":"sale","acquired":false,"shares":1000,"price":31.6,"value":31600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.01 to $32.42, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":163390,"source":{"system":"sec-edgar","filing":"0001595585-19-000142","document":"wf-form4_156444099519993.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000142/wf-form4_156444099519993.xml","form_type":"4"}},{"id":3466936,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-05T20:56:08.000Z","date":"2019-07-03","kind":"sale","acquired":false,"shares":3000,"price":37.05,"value":111150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.03 to $38.53, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,879 restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of May 31, 2019 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":164390,"source":{"system":"sec-edgar","filing":"0001595585-19-000122","document":"wf-form4_156236015351095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000122/wf-form4_156236015351095.xml","form_type":"4"}},{"id":115539,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-07-02T17:13:38.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":94,"price":72.72,"value":6835.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6571,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":94},"source":{"system":"sec-edgar","filing":"0001179110-19-008308","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911019008308/edgar.xml","form_type":"4"}},{"id":401827,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-07-01T21:02:16.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":93,"price":84.1,"value":7821.3,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7524,"derivative":{"underlying":"Common shares","underlying_shares":93},"source":{"system":"sec-edgar","filing":"0001179110-19-008246","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008246/edgar.xml","form_type":"4"}},{"id":3502211,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-05T00:26:30.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":7068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's continuous service to the Issuer as a non-employee director through each vesting date, this option vests ratably on a monthly basis, on the monthly anniversary of May 31, 2019 (\"Option Date\"), over the one-year period following the Option Date so that the option shall be 100% vested and exercisable on the one-year anniversary of the Option Date (\"Vesting Date\"); provided, however, if the Next Annual Meeting occurs prior to the Vesting Date, then the option shall vest in full immediately prior to the Next Annual Meeting."}],"balance_after":7068,"derivative":{"exercise_price":36.74,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":7068},"source":{"system":"sec-edgar","filing":"0001595585-19-000102","document":"wf-form4_155969437584754.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000102/wf-form4_155969437584754.xml","form_type":"4"}},{"id":3502210,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-05T00:26:30.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":1879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of May 31, 2019 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":167390,"source":{"system":"sec-edgar","filing":"0001595585-19-000102","document":"wf-form4_155969437584754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000102/wf-form4_155969437584754.xml","form_type":"4"}},{"id":116872,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value","published_at":"2019-05-07T20:49:35.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":2419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":26107,"source":{"system":"sec-edgar","filing":"0001179110-19-005666","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911019005666/edgar.xml","form_type":"4"}},{"id":403748,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2019-04-30T21:18:47.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":2241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":30406,"source":{"system":"sec-edgar","filing":"0001179110-19-005307","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019005307/edgar.xml","form_type":"4"}},{"id":404619,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-04-02T23:44:10.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":98,"price":79.94,"value":7834.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7400,"derivative":{"underlying":"Common shares","underlying_shares":98},"source":{"system":"sec-edgar","filing":"0001179110-19-004612","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019004612/edgar.xml","form_type":"4"}},{"id":117891,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-04-02T21:05:24.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":85,"price":80.59,"value":6850.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6389,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":85},"source":{"system":"sec-edgar","filing":"0001179110-19-004524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000117911019004524/edgar.xml","form_type":"4"}},{"id":3573971,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T21:25:50.000Z","date":"2019-03-28","kind":"sale","acquired":false,"shares":14000,"price":33.63,"value":470820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $36.00, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,632 shares of restricted stock units (\"RSUs\") that vest on the earlier of (i) the one-year anniversary of June 27, 2018 (the \"Grant Date\") and (ii) the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date (the \"Next Annual Meeting\"), subject to the Reporting Person's continuous service as a non-employee director through such vesting date.  Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":165511,"source":{"system":"sec-edgar","filing":"0001595585-19-000065","document":"wf-form4_155389473471127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448074/000159558519000065/wf-form4_155389473471127.xml","form_type":"4"}},{"id":409304,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2019-01-03T22:23:24.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":108,"price":72.33,"value":7811.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7270,"derivative":{"underlying":"Common shares","underlying_shares":108},"source":{"system":"sec-edgar","filing":"0001179110-19-000293","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019000293/edgar.xml","form_type":"4"}}],"next_cursor":"2019-01-03T22:23:24.000000Z,409304"}